Recent developments of interest in cardiovascular medicine
The atrial fibrillation that implanted loop recorders find in people without a known history of it is rarely symptomatic and doesn't often progress, a "natural history" study reported in the Journal of the American College of Cardiology (JACC).
Cost is behind medication nonadherence for one in eight atherosclerotic heart disease patients. (Circulation)
How much salmon would it take to equal the omega-3s from icosapent ethyl (Vascepa)? NPR has the answer.
With a heart rate dipping as low as 2 beats per minute, the largest creature the planet has ever seen may represent the limits of what's biologically possible for a cardiovascular system, Gizmodo reports.
Testing positive for troponin -- even if only slightly elevated -- is linked to "clinically important increased mortality, regardless of age," mainly in the first few weeks, a study showed in The BMJ.
Despite an overhaul of the heart transplant allocation system in 2018, some centers still have better survival than others and ranking of candidates isn't standardized. (JAMA, Cardiovascular Business)
Transparent data sharing and collaboration among centers that perform complex pediatric cardiac surgery reduced mortality and complications of these procedures, researchers reported in JACC.
LivaNova announced it stopped development on its Caisson transcatheter mitral valve replacement device.
Another serious injury and two deaths have been reported with Getinge's Maquet/Datascope intra-aortic balloon pumps since the FDA cautioned last year about the devices shutting down while on battery power.
Physicians don't see their doctor or get preventive testing as much as the general public, but they have better outcomes anyway, a Canadian study showed in JAMA Network Open. (Cardiovascular Business)
In 1-year preliminary outcomes from the pivotal TRILUMINATE study, a modified version of the MitraClip -- the TriClip device -- improved tricuspid regurgitation by at least one grade in 87% of symptomatic or worse patients and improved quality-of-life, researchers reported at London Valves.
Real-world data from the TransCarotid Artery Revascularization (TCAR) Surveillance Project showed this treatment was on par with carotid endarterectomy surgery for in-hospital stroke and death, Silk Road Medical announced from the study reported at the VEITHsymposium. (Cath Lab Digest)
Read the original article on Medpage Today: Loop Recorder Natural History; Cruising at 2 BPM; Tricuspid Clip